BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20014119)

  • 21. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sixth international RASopathies symposium: Precision medicine-From promise to practice.
    Gripp KW; Schill L; Schoyer L; Stronach B; Bennett AM; Blaser S; Brown A; Burdine R; Burkitt-Wright E; Castel P; Darilek S; Dias A; Dyer T; Ellis M; Erickson G; Gelb BD; Green T; Gross A; Ho A; Holder JL; Inoue SI; Jelin AC; Kennedy A; Klein R; Kontaridis MI; Magoulas P; McConnell DB; McCormick F; Neel BG; Prada CE; Rauen KA; Roberts A; Rodriguez-Viciana P; Rosen N; Rumbaugh G; Sablina A; Solman M; Tartaglia M; Thomas A; Timmer WC; Venkatachalam K; Walsh KS; Wolters PL; Yi JS; Zenker M; Ratner N
    Am J Med Genet A; 2020 Mar; 182(3):597-606. PubMed ID: 31825160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.
    Stevenson DA; Schill L; Schoyer L; Andresen BS; Bakker A; Bayrak-Toydemir P; Burkitt-Wright E; Chatfield K; Elefteriou F; Elgersma Y; Fisher MJ; Franz D; Gelb BD; Goriely A; Gripp KW; Hardan AY; Keppler-Noreuil KM; Kerr B; Korf B; Leoni C; McCormick F; Plotkin SR; Rauen KA; Reilly K; Roberts A; Sandler A; Siegel D; Walsh K; Widemann BC
    Am J Med Genet A; 2016 Aug; 170(8):1959-66. PubMed ID: 27155140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
    Tidyman WE; Rauen KA
    Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RASopathies: Dermatologists' viewpoints.
    Palit A; Inamadar AC
    Indian J Dermatol Venereol Leprol; 2022; 88(4):452-463. PubMed ID: 35138057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway.
    Kleefstra T; Wortmann SB; Rodenburg RJ; Bongers EM; Hadzsiev K; Noordam C; van den Heuvel LP; Nillesen WM; Hollody K; Gillessen-Kaesbach G; Lammens M; Smeitink JA; van der Burgt I; Morava E
    Eur J Hum Genet; 2011 Feb; 19(2):138-44. PubMed ID: 21063443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rasopathies: developmental disorders that predispose to cancer and skin manifestations].
    Hernández-Martín A; Torrelo A
    Actas Dermosifiliogr; 2011; 102(6):402-16. PubMed ID: 21536246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.
    Kontaridis MI; Roberts AE; Schill L; Schoyer L; Stronach B; Andelfinger G; Aoki Y; Axelrad ME; Bakker A; Bennett AM; Broniscer A; Castel P; Chang CA; Cyganek L; Das TK; den Hertog J; Galperin E; Garg S; Gelb BD; Gordon K; Green T; Gripp KW; Itkin M; Kiuru M; Korf BR; Livingstone JR; López-Juárez A; Magoulas PL; Mansour S; Milner T; Parker E; Pierpont EI; Plouffe K; Rauen KA; Shankar SP; Smith SB; Stevenson DA; Tartaglia M; Van R; Wagner ME; Ware SM; Zenker M
    Am J Med Genet A; 2022 Jun; 188(6):1915-1927. PubMed ID: 35266292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RASopathies and cardiac manifestations.
    Hilal N; Chen Z; Chen MH; Choudhury S
    Front Cardiovasc Med; 2023; 10():1176828. PubMed ID: 37529712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RASopathies: from pathogenetics to therapeutics.
    Hebron KE; Hernandez ER; Yohe ME
    Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35178568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RASopathies for Radiologists.
    Handa A; Tsujioka Y; Nishimura G; Nozaki T; Kono T; Jinzaki M; Harms T; Connolly SA; Sato TS; Sato Y
    Radiographics; 2024 May; 44(5):e230153. PubMed ID: 38602868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.
    Pierpont EI; Bennett AM; Schoyer L; Stronach B; Anschutz A; Borrie SC; Briggs B; Burkitt-Wright E; Castel P; Cirstea IC; Draaisma F; Ellis M; Fear VS; Frone MN; Flex E; Gelb BD; Green T; Gripp KW; Khoshkhoo S; Kieran MW; Kleemann K; Klein-Tasman BP; Kontaridis MI; Kruszka P; Leoni C; Liu CZ; Merchant N; Magoulas PL; Moertel C; Prada CE; Rauen KA; Roelofs R; Rossignol R; Sevilla C; Sevilla G; Sheedy R; Stieglitz E; Sun D; Tiemens D; White F; Wingbermühle E; Wolf C; Zenker M; Andelfinger G
    Am J Med Genet A; 2024 Apr; 194(4):e63477. PubMed ID: 37969032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.
    Korf B; Ahmadian R; Allanson J; Aoki Y; Bakker A; Wright EB; Denger B; Elgersma Y; Gelb BD; Gripp KW; Kerr B; Kontaridis M; Lazaro C; Linardic C; Lozano R; MacRae CA; Messiaen L; Mulero-Navarro S; Neel B; Plotkin S; Rauen KA; Roberts A; Silva AJ; Sittampalam SG; Zhang C; Schoyer L
    Am J Med Genet A; 2015 Aug; 167A(8):1741-6. PubMed ID: 25900621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
    Zenker M
    Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignancy in Noonan syndrome and related disorders.
    Smpokou P; Zand DJ; Rosenbaum KN; Summar ML
    Clin Genet; 2015 Dec; 88(6):516-22. PubMed ID: 25683281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update on the treatment of RASopathies].
    Duat-Rodriguez A; Hernandez-Martin A
    Rev Neurol; 2017 May; 64(s03):S13-S17. PubMed ID: 28524213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RASopathies: Biology, genetics and therapeutic options.
    Longo JF; Carroll SL
    Adv Cancer Res; 2022; 153():305-341. PubMed ID: 35101235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rasopathies case report: concurrence of two pathogenic variations de novo in NF1 and KRAS genes in a patient.
    Baquedano Lobera I; Izquierdo Álvarez S; Oliván Del Cacho MJ
    BMC Pediatr; 2019 Apr; 19(1):92. PubMed ID: 30953504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.